Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 7, 2012; 18(37): 5188-5196
Published online Oct 7, 2012. doi: 10.3748/wjg.v18.i37.5188
Published online Oct 7, 2012. doi: 10.3748/wjg.v18.i37.5188
Table 1 Clinical characteristics of participants in validation
Group | CHB | NASH | Ctrl |
Individuals (n) | 24 | 20 | 24 |
Gender (n) | |||
Male | 21 | 17 | 19 |
Female | 3 | 3 | 5 |
Age (yr) | 37.6 ± 9.0 | 39.4 ± 9.6 | 35.6 ± 10.2 |
ALT (IU/L) | 82.6 (14-412) | 51.7 (18-203) | 21.5 (14-43) |
AST (IU/L) | 62.6 (9-206) | 31.55 (17-62) | 21.4 (16-49) |
GGT (IU/L) | 69.4 (10-580) | 45.8 (13-124) | 20.8 (12-33) |
ALP (IU/L) | 95.8 (51-211) | 66.0 (41-90) | 62.3 (42-96) |
TBIL (μmol/L) | 19.2 (10.2-50.7) | 19.5 (13.1-31.7) | 15.9 (6.9-27.1) |
HBV DNA | 7 377 395 (0-94 800 000) | 0 | 0 |
Bile acid (μmol/L) | 6.9 (1.4-13) | 17.9 (3-118.7) | 8.4 (4.1-12) |
HBV status (n) | |||
HBsAg+ | 24 | 0 | 0 |
HBsAg- | 0 | 20 | 24 |
- Citation: Zhang H, Li QY, Guo ZZ, Guan Y, Du J, Lu YY, Hu YY, Liu P, Huang S, Su SB. Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B. World J Gastroenterol 2012; 18(37): 5188-5196
- URL: https://www.wjgnet.com/1007-9327/full/v18/i37/5188.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i37.5188